Recovery of Leukotriene E4 from the Urine of Patients with Airway Obstruction
Authors:
- Jeanne O'BRienJOJeanne O'BRien
- David SparrowDSDavid Sparrow
- Scott T. WeissSWScott T. Weiss
- Milton A. MartinsMMMilton A. Martins
- Elliot IsraelEIElliot Israel
- Christopher H. FantaCFChristopher H. Fanta
- 1 July 1992
- journal article
- research article
- Published by Oxford University Press (OUP) in American Review of Respiratory Disease
- Vol. 146 (1) , 104-108
Abstract
The urinary excretion of leukotriene E4 (LTE4) was measured in subjects presenting for emergency treatment of airway obstruction. A total of 72 subjects presenting with airway obstruction performed peak flow determinations before and after three treatments with nebulized albuterol given at 20-min intervals. Of these subjects, 22 more than doubled their peak flow rates, while 19 failed to increase their peak flow rates more than 25% during the treatment period. These groups were designated “responders” and “nonresponders,” respectively. Urinary LTE4 excretion was determined in 16 of the 22 responders and 12 of the 19 nonresponders as well as 13 normal subjects by precolumn extraction, analytic reversed-phase high-performance liquid chromatography, and enzyme immunoassay. In the normal subjects the urinary LTE4 excretion was significantly (p < 0.0001) less than the urinary LTE4 measured in the responder subjects, but not less than the urinary LTE4 excretion in the nonresponder group (p = 0.071). The enhanced recovery of LTE4 from the urine of subjects with acutely reversible airway narrowing is consistent with a bronchoconstrictor role for the cysteinyl leukotrienes in spontaneous acute asthma.Keywords
This publication has 12 references indexed in Scilit:
- The Roles of Inflammatory Cells in the Pathogenesis of Asthma and of Chronic Obstructive Pulmonary DiseaseAmerican Review of Respiratory Disease, 1991
- The Influence of Age and Level of Pulmonary Function on Nonspecific Airway Responsiveness: The Normative Aging StudyAmerican Review of Respiratory Disease, 1991
- Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients.Thorax, 1991
- Inhibition of Exercise-Induced Bronchoconstriction by MK-571, a Potent Leukotriene D4–Receptor AntagonistNew England Journal of Medicine, 1990
- Elevated Levels of Leukotriene C4 in Bronchoalveolar Lavage Fluid from Atopic Asthmatics after Endobronchial Allergen ChallengeAmerican Review of Respiratory Disease, 1990
- Effect of a Leukotriene Antagonist, LY171883, on Cold Air-induced Bronchoconstriction in AsthmaticsAmerican Review of Respiratory Disease, 1989
- A Specific LTD4/LTE4receptor Antagonist Improves Pulmonary Function in Patients with Mild, Chronic AsthmaAmerican Review of Respiratory Disease, 1989
- The effect of an oral leukotriene D4 antagonist L-649,923 on the response to inhaled antigen in asthma*1Journal of Allergy and Clinical Immunology, 1987
- Plasma Levels of Leukotrienes C4 and D4 during Wheezing Attack in Asthmatic PatientsInternational Archives of Allergy and Immunology, 1987
- A Controlled Trial of Methylprednisolone in the Emergency Treatment of Acute AsthmaNew England Journal of Medicine, 1986